Literature DB >> 23246138

Validation of the Modified Fatigue Impact Scale in Parkinson's disease.

Dawn M Schiehser1, Catherine R Ayers, Lin Liu, Stephanie Lessig, David S Song, J Vincent Filoteo.   

Abstract

INTRODUCTION: Fatigue is a common symptom in Parkinson's disease (PD); however, a multidimensional scale that measures the impact of fatigue on functioning has yet to be validated in this population. The aim of this study was to examine the validity of the Modified Fatigue Impact Scale (MFIS), a self-report measure that assesses the effects of fatigue on physical, cognitive, and psychosocial functioning, in a sample of nondemented PD patients.
METHODS: PD patients (N = 100) completed the MFIS, the Positive and Negative Affect Schedule (PANAS-X), and several additional measures of psychosocial, cognitive, and motor functioning. A Principal Component Analysis (PCA) and item analysis using Cronbach's alpha were conducted to determine structural validity and internal consistency of the MFIS. Correlational analyses were performed between the MFIS and the PANAS-X fatigue subscale to evaluate convergent validity and between the MFIS and measures of depression, anxiety, apathy, and disease-related symptoms to determine divergent validity.
RESULTS: The PCA identified two viable MFIS subscales: a cognitive subscale and a combination of the original scale's physical and psychosocial subscales as one factor. Item analysis revealed high internal consistency of all 21 items and the items within the two subscales. The MFIS had strong convergent validity with the PANAS-X fatigue subscale and adequate divergent validity with measures of disease stage, motor function, and cognition.
CONCLUSION: Overall, this study demonstrates that the MFIS is a valid multidimensional measure that can be used to evaluate the impact of fatigue on cognitive and physical/social functioning in PD patients without dementia. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23246138     DOI: 10.1016/j.parkreldis.2012.11.013

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  13 in total

1.  Factors Associated With Ambulatory Activity in De Novo Parkinson Disease.

Authors:  Cory Christiansen; Charity Moore; Margaret Schenkman; Benzi Kluger; Wendy Kohrt; Anthony Delitto; Brian Berman; Deborah Hall; Deborah Josbeno; Cynthia Poon; Julie Robichaud; Toby Wellington; Samay Jain; Cynthia Comella; Daniel Corcos; Ed Melanson
Journal:  J Neurol Phys Ther       Date:  2017-04       Impact factor: 3.649

Review 2.  Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.

Authors:  Benzi M Kluger; Karen Herlofson; Kelvin L Chou; Jau-Shin Lou; Christopher G Goetz; Anthony E Lang; Daniel Weintraub; Joseph Friedman
Journal:  Mov Disord       Date:  2016-02-16       Impact factor: 10.338

3.  Adapted physical activity and therapeutic exercise in late-onset Pompe disease (LOPD): a two-step rehabilitative approach.

Authors:  Giovanni Iolascon; Michele Vitacca; Elena Carraro; Carmelo Chisari; Pietro Fiore; Sonia Messina; Tiziana Mongini; Antimo Moretti; Valeria A Sansone; Antonio Toscano; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2019-12-07       Impact factor: 3.307

4.  Alterations in regional homogeneity of resting-state brain activity in fatigue of Parkinson's disease.

Authors:  Junyi Li; Yongsheng Yuan; Min Wang; Jiejin Zhang; Li Zhang; Siming Jiang; Jian Ding; Kezhong Zhang
Journal:  J Neural Transm (Vienna)       Date:  2017-06-24       Impact factor: 3.575

5.  Fatigue is associated with worse cognitive and everyday functioning in older persons with HIV.

Authors:  Laura M Campbell; Ni Sun-Suslow; Anne Heaton; Robert K Heaton; Ronald J Ellis; David J Moore; Raeanne C Moore
Journal:  AIDS       Date:  2022-01-06       Impact factor: 4.632

6.  Fatigue in Parkinson's disease: report from a mutidisciplinary symposium.

Authors:  Joseph H Friedman; James C Beck; Kelvin L Chou; Gracia Clark; Christopher P Fagundes; Christopher G Goetz; Karen Herlofson; Benzi Kluger; Lauren B Krupp; Anthony E Lang; Jao-Shin Lou; Laura Marsh; Anne Newbould; Daniel Weintraub
Journal:  NPJ Parkinsons Dis       Date:  2016-01-14

7.  Assessment of fatigue in Parkinson's disease: Indian perspective.

Authors:  Birinder Singh Paul; Amandeep Singh; Dinesh Jain; Gagandeep Singh; Sandeep Kaushal; Gunchan Paul; Karan Kaura
Journal:  Ann Indian Acad Neurol       Date:  2016 Oct-Dec       Impact factor: 1.383

8.  Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson's Disease Patients.

Authors:  U Hidding; A Gulberti; A Horn; C Buhmann; W Hamel; J A Koeppen; M Westphal; A K Engel; C Gerloff; D Weiss; C K E Moll; M Pötter-Nerger
Journal:  Parkinsons Dis       Date:  2017-01-26

9.  Reliability and validity of the persian version of the fatigue severity scale in idiopathic Parkinson's disease patients.

Authors:  Seyed-Mohammad Fereshtehnejad; Hasti Hadizadeh; Farzaneh Farhadi; Gholam Ali Shahidi; Ahmad Delbari; Johan Lökk
Journal:  Parkinsons Dis       Date:  2013-09-05

10.  The effects of anxiety and external attentional focus on postural control in patients with Parkinson's disease.

Authors:  Seyede Zohreh Jazaeri; Akram Azad; Hajar Mehdizadeh; Seyed Amirhassan Habibi; Mahbubeh Mandehgary Najafabadi; Zakieh Sadat Saberi; Hawre Rahimzadegan; Saeed Moradi; Saeed Behzadipour; Mohamad Parnianpour; Ghorban Taghizadeh; Kinda Khalaf
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.